Icelandic startup bags €6M EU grant to fight drug-resistant infections
It will address infections triggered by bacteria, viruses, and fungi. Thestartups work builds on the research of the University of Iceland, which is one the companys owners. 40% off TNW Conference! Upon completion, IN-ARMOR will move to clinical validation. If successful, IN-ARMOR would have the potential to save long-term 107 billion in antibiotics development. Story byIoanna Lykiardopoulou Ioanna is a writer at TNW. With a background in the humanities, she has a soft spot for social impact-enabling technologies....